Tirzepatide
Availability In clinic
What it is
Tirzepatide is a prescription medication that activates receptors for two gut hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), which is one reason it's often discussed separately from single-mechanism GLP-1 drugs like semaglutide. It's sold as Zepbound for weight management and Mounjaro for type 2 diabetes, and like semaglutide, it's a prescription medication, not a supplement.
Why people take it
People take tirzepatide for substantial weight loss, and increasingly for obstructive sleep apnea, for which Zepbound became the first FDA-approved medication. In longevity terms, it's used when excess weight, insulin resistance, or sleep apnea are driving broader metabolic risk, with the target defined up front rather than treated as a generic anti-aging goal.
How it's delivered
Like other GLP-1-class drugs, tirzepatide is a once-weekly injection from a pre-filled pen, started at a low dose and increased on a schedule over weeks to months, usually at least four weeks at each step, so the body can adjust before reaching the target dose. A provider oversees the pace and can slow it down if side effects are hard to tolerate.
Where the evidence stands
Tirzepatide's weight-loss data is some of the strongest in the class: the SURMOUNT-1 trial showed large reductions in adults with obesity, and a head-to-head trial found it outperformed semaglutide for weight loss. It's also the first medication approved for moderate-to-severe obstructive sleep apnea in adults with obesity. Continued treatment appears necessary to hold the results, since switching to placebo leads to regain, and no trial has tested whether it extends lifespan in otherwise healthy people.
Estimated cost
- Zepbound self-pay $299–$699/mo by dose (LillyDirect, vials or KwikPen); $449/mo at the higher doses with on-time refills
- Mounjaro: no self-pay price published; as low as $499 for a one-month fill with the savings card and no coverage
- $90–$399/mo compounded through telehealth; some add a membership fee
- Source: Lilly and the compared providers' own sites, checked 21 Oct 2026
- Rarely covered by insurance for weight loss alone
Who offers it
Observed at Next Health, Human Longevity, Defy Medical, Maximus, and AgelessRx, among others.
Go deeper
The full guide, GLP-1s and Longevity, covers how tirzepatide compares with semaglutide and the complete evidence picture.
Longevity.io is for educational purposes only and is not medical advice. Whether tirzepatide belongs in your plan is a conversation for a clinician who knows your situation. Confirm eligibility, services, and pricing directly with any provider.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
